Dovitinib Lactate

4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo-[d]imidazol-2-yl)quinolin-2(1H)-one 2-hyd CHIR-258, TKI-258 Dovitinib Lactate Salt 4-Amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-benzo-[d]imidazol-2-yl)quinolin-2(1H)-one 2- Propanoic acid, 2-hydroxy-, coMpd. with 4-aMino-5-fluoro-3-[6-(4 4-AMino-5-fluoro-3-[6-(4-Methyl-1-piperazinyl)-1H-benziMidazol-2-yl]-2(1H)-quinolinone 2-Hydroxypropanoic Acid Propanoic acid, 2-hydroxy-, coMpd. with 4-aMino-5-fluoro-3-[6-(4-Methyl-1-piperazinyl)-1H-benziMidazol-2-yl]-2(1H)-quinolinone (1:1) ,(lactate salt) 4-AMino-5-fluoro-3-(6-(4-Methylpiperazin-1-yl)-1H-benzo[d]iMidazol-2-yl)quinolin-2(1H)-one 2-hydroxypropanoate Dovitinib lactate Dovitinib (CHIR-258) lactate TKI 258 Dovitinib Lactate CHIR-258 lactate CHIR-258 LACTATE; TKI-258 LACTATE (3Z)-4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1,3-dihydrobenzimidazol-2-ylidene]quinolin-2-one FGFR,CHIR-258,Dovitinib,c-Kit,SCFR,PDGFR,CD117,Platelet-derived growth factor receptor,TKI258,VEGFR,TKI 258,CHIR258,CD135,FLT3,Dovitinib lactate,CHIR 258,Fms like tyrosine kinase 3,Inhibitor,Cluster of differentiation antigen 135,Vascular endothelial growth factor receptor,inhibit,TKI-258,Fibroblast growth factor receptor 692737-80-7 C24H27FN6O4 C21H21FN6OC3H6O3 Antineoplastic Amines Heterocycles Intermediates & Fine Chemicals Pharmaceuticals